Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 15173273

Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Natl Cancer Inst
Publication date
2004 Jun 2
First author
Saad F

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Natl Cancer Inst. 2004 Oct 6;96(19):1480; author reply 1480-1. doi: 10.1093/jnci/djh294.
    note
    Source null
    related pmid
    15467039
    relationship
    Comment in
  2. citation
    J Natl Cancer Inst. 2005 Jan 5;97(1):70; author reply 70-1. doi: 10.1093/jnci/dji016.
    note
    Source null
    related pmid
    15632382
    relationship
    Comment in
  3. citation
    J Natl Cancer Inst. 2005 Feb 2;97(3):235-6. doi: 10.1093/jnci/dji037.
    note
    Source null
    related pmid
    15687369
    relationship
    Comment in

Authors and identifiers

  1. name
    Saad F
    type
    Author
  2. name
    Gleason DM
    type
    Author
  3. name
    Murray R
    type
    Author
  4. name
    Tchekmedyian S
    type
    Author
  5. name
    Venner P
    type
    Author
  6. name
    Lacombe L
    type
    Author
  7. name
    Chin JL
    type
    Author
  8. name
    Vinholes JJ
    type
    Author
  9. name
    Goas JA
    type
    Author
  10. name
    Zheng M
    type
    Author
  11. name
    Zoledronic Acid Prostate Cancer Study Group
    type
    CollectiveName
Complete bibliographic record and source provenance
authors
  1. name
    Saad F
    type
    Author
  2. name
    Gleason DM
    type
    Author
  3. name
    Murray R
    type
    Author
  4. name
    Tchekmedyian S
    type
    Author
  5. name
    Venner P
    type
    Author
  6. name
    Lacombe L
    type
    Author
  7. name
    Chin JL
    type
    Author
  8. name
    Vinholes JJ
    type
    Author
  9. name
    Goas JA
    type
    Author
  10. name
    Zheng M
    type
    Author
  11. name
    Zoledronic Acid Prostate Cancer Study Group
    type
    CollectiveName
bibliography ids
  1. nci-bib-f11a8afd3f765af4fc5f69de
book metadata
content sha256
c757d48758f3d688b97ed4dd435c163937481cd6b9e7d8ee5180a277e5b1f9b5
document type
citation
dois
  1. 10.1093/jnci/djh141
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:15173273
immutable id
pubmed:15173273@c757d48758f3d688b97ed4dd435c163937481cd6b9e7d8ee5180a277e5b1f9b5
journal
abbreviation
J Natl Cancer Inst
issn electronic
1460-2105
issn print
0027-8874
issue
11
name
Journal of the National Cancer Institute
nlm unique id
7503089
pages
879-82
volume
96
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Natl Cancer Inst. 2004 Oct 6;96(19):1480; author reply 1480-1. doi: 10.1093/jnci/djh294.
    note
    Source null
    related pmid
    15467039
    relationship
    Comment in
  2. citation
    J Natl Cancer Inst. 2005 Jan 5;97(1):70; author reply 70-1. doi: 10.1093/jnci/dji016.
    note
    Source null
    related pmid
    15632382
    relationship
    Comment in
  3. citation
    J Natl Cancer Inst. 2005 Feb 2;97(3):235-6. doi: 10.1093/jnci/dji037.
    note
    Source null
    related pmid
    15687369
    relationship
    Comment in
outcomes validated
false
pmid
15173273
provenance
batch id
748437a772c9631ad901
provider
NCBI PubMed ESummary
record sha256
ec5c7e668263c9ee8c9691533436da054d1be09e1e379c47023561424e15c8e9
response sha256
1535c16de1ca2ef53b01ccf9e7709049035aa1b159955f06fbec3d1a0daddc80
retrieved at
2026-09-09T23:45:55.399079+00:00
publication date
display
2004 Jun 2
precision
day
year
2004
publication types
  1. Clinical Trial
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/15173273/
title
Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.

Preserved source evidence · Not medical advice